Skip to main content

Table 1 Patient characteristics and outcomes of those who developed pulmonary cavitation

From: Pulmonary cavitation: an under-recognized late complication of severe COVID-19 lung disease

  Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7 Patient 8 Patient 9 Patient 10 Patient 11 Patient 12
Age range 50–59 40–49 60–69 40–49 60–69 50–59 40–49 30–39 40–49 50–59 30–39 40–49
BMI 30.9 30.4 31.3 29.2 25.1 29.4 26.3 21.5 30.1 19.8 24 27.7
Comorbidities DM, HT HT DM DM COPD HT HT   DM, HT DM DM DM
On admission
 Time from symptom onset to intubation (days) 6 12 9 7 5 5 8 15 3 9 10 8
 P/F ratio 48.8 41.6 49.7 33.0 46.1 47.0 65.3 41.8 70.5 100.1 109.4 104.5
 SOFA score (points) 24 21 24 25 23 23 16 21 25 23 18 17
 Neutropenia            Y  
 Leucocytes (× 10 * 9/L) 0.49 1.35 0.3 2.78 0.6 1.1 1.66 1.03 0.46 2.91 1.62 2.63
During the admission
 NM blockade Y Y Y Y Y Y Y Y Y    Y
 VTE   DVT and PE     PE DVT    DVT   
 CVA Y          Y   
 CRRT/IHD   Y Y Y Y Y    Y    Y
 ECMO        Y Y Y    
 Proned Y Y Y Y Y Y   Y Y Y   
 Tracheostomy Y   Y Y Y Y Y Y Y    
 Days of systemic CS 17 15 19 24 11 14 14 25 18 9 6 5
 + ve fungal cultures or serology   Y Y Y   Y    Y    
 Treated for fungal infection Y Y Y Y   Y Y   Y    Y
 Duration of hospital stay (days) 37 25 53 33 53 74 101 133 57 56 47 40
Outcome
  Deceased Deceased Deceased Deceased Deceased Deceased Discharged home Discharged home Discharged home Discharged home Discharged home Discharged home
  1. BMI body mass index, P/F ratio PaO2/FiO2, SOFA sequential organ failure assessment, NM neuromuscular, Y yes, VTE venous thromboembolism, DVT deep vein thrombosis, PE pulmonary embolus, CVA cerebrovascular accident, CRRT continuous renal replacement therapy, IHD intermittent hemodialysis, ECMO extracorporeal membrane oxygenation, CS corticosteroids